Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 14/20 | 0.42 |
| ▸ | RXRA | P19793 | 13/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 13/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 2/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30890482 | 0.91 | POLB (0.40) | NR1H2RXRANR1H3POLBHSD17B10 | |
| SCHEMBL30992285 | 0.90 | IMPDH2 (0.41) | NR1H2RXRANR1H3POLBHSD17B10 | |
| SCHEMBL27244874 | 0.86 | IMPDH2 (0.35) | NR1H2RXRANR1H3 | |
| SCHEMBL27245066 | 0.85 | OTUD7B (0.43) | NR1H2RXRANR1H3MAPK1 | |
| SCHEMBL27245125 | 0.85 | MAPT (0.38) | POLBHSD17B10MAPTBRD4CREBBP | |
| SCHEMBL30890444 | 0.82 | POLB (0.36) | POLBHSD17B10MAPTMAPK1 | |
| SCHEMBL27245181 | 0.82 | NR1H2 (0.44) | NR1H2RXRANR1H3MAPTBRD4 | |
| SCHEMBL25240372 | 0.78 | NR1H2 (0.51) | NR1H2RXRANR1H3 | |
| SCHEMBL3664778 | 0.78 | NR1H2 (0.51) | NR1H2RXRANR1H3 | |
| SCHEMBL6521416 | 0.78 | NR1H2 (0.51) | NR1H2RXRANR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |